This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2009 Sep 24;361(13):1230-3.

doi: 10.1056/NEJMp0906490. Epub 2009 Aug 12.

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling

Randall S Stafford¹, Todd H Wagner, Philip W Lavori

Affiliations

PMID: 19675326
DOI: 10.1056/NEJMp0906490

Free article

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling

Randall S Stafford et al. N Engl J Med. 2009.

Free article

. 2009 Sep 24;361(13):1230-3.

doi: 10.1056/NEJMp0906490. Epub 2009 Aug 12.

Authors

Randall S Stafford¹, Todd H Wagner, Philip W Lavori

Affiliation

¹ Stanford Prevention Research Center, Stanford University, Palo Alto, California, USA.

PMID: 19675326
DOI: 10.1056/NEJMp0906490

No abstract available

PubMed Disclaimer

Similar articles

FDA defends generic drug labeling plan.
Traynor K. Traynor K. Am J Health Syst Pharm. 2014 May 15;71(10):770-3. doi: 10.2146/news140035. Am J Health Syst Pharm. 2014. PMID: 24780477 No abstract available.
FDA mulls over paperless labeling.
Young D. Young D. Am J Health Syst Pharm. 2007 Jun 1;64(11):1120, 1122. doi: 10.2146/news070049. Am J Health Syst Pharm. 2007. PMID: 17519446 No abstract available.
Regulating off-label drug use--rethinking the role of the FDA.
Stafford RS. Stafford RS. N Engl J Med. 2008 Apr 3;358(14):1427-9. doi: 10.1056/NEJMp0802107. N Engl J Med. 2008. PMID: 18385495 No abstract available.
FDA Regulation of Prescription Drugs.
Gassman AL, Nguyen CP, Joffe HV. Gassman AL, et al. N Engl J Med. 2017 Feb 16;376(7):674-682. doi: 10.1056/NEJMra1602972. N Engl J Med. 2017. PMID: 28199811 Review. No abstract available.
The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC, King TL. Brucker MC, et al. J Midwifery Womens Health. 2017 May;62(3):308-316. doi: 10.1111/jmwh.12611. Epub 2017 May 29. J Midwifery Womens Health. 2017. PMID: 28556499 Review.

See all similar articles

Cited by

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.
Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Walker D, Kelly C, Birrell F, Chakravarty K, Maddison P, Heslin M, Patel A, Kingsley GH. Scott DL, et al. BMJ. 2015 Mar 13;350:h1046. doi: 10.1136/bmj.h1046. BMJ. 2015. PMID: 25769495 Free PMC article. Clinical Trial.
Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.
Bourgeois FT, Murthy S, Mandl KD. Bourgeois FT, et al. PLoS One. 2012;7(1):e28820. doi: 10.1371/journal.pone.0028820. Epub 2012 Jan 9. PLoS One. 2012. PMID: 22253698 Free PMC article.
Substituting placebo for established, effective therapy: why not?
Shapiro S, Fergusson D, Glass KC. Shapiro S, et al. CMAJ. 2010 Nov 9;182(16):1749-53. doi: 10.1503/cmaj.090548. Epub 2010 Jun 14. CMAJ. 2010. PMID: 20547712 Free PMC article. Review. No abstract available.
A critique of narrative reviews of the evidence-base for ECT in depression.
Meechan CF, Laws KR, Young AH, McLoughlin DM, Jauhar S. Meechan CF, et al. Epidemiol Psychiatr Sci. 2022 Jan 27;31:e10. doi: 10.1017/S2045796021000731. Epidemiol Psychiatr Sci. 2022. PMID: 35083968 Free PMC article. Review.
US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research.
Neumann PJ, Lin PJ, Hughes TE. Neumann PJ, et al. Pharmacoeconomics. 2011 Aug;29(8):687-92. doi: 10.2165/11590510-000000000-00000. Pharmacoeconomics. 2011. PMID: 21732704

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K24 HL086703/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.